IL1B and ocular melanoma: On the molecular level, a release of reactive oxygen species (ROS) and pro-inflammatory cytokines such as Interleukin 1 Beta (IL-1β) and Interleukin 6 (IL-6) that initiate inflammation is thought to be the starting point of OM (10).